Abstract
3613 Background: Clinical trials have demonstrated a survival benefit of oxaliplatin (OX)- or irinotecan (IRI)-based combination chemotherapy regimens for treatment of stage IV colon cancer patient...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have